Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 3/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22944159 | 0.92 | SCN10A (0.61) | HTR3ASCN10AHTR2C | |
| Trifluoroacetic Acid SCHEMBL21381947 | 0.90 | HTR2C (0.50) | HTR3ASCN10AHTR2CEPHX1 | |
| SCHEMBL2298335 | 0.90 | HTR2C (0.61) | SCN10AHTR2CEPHX1 | |
| Hydrochloric Acid SCHEMBL4893644 | 0.88 | HTR2C (0.62) | SCN10AHTR2CEPHX1 | |
| SCHEMBL14744263 | 0.86 | SCN10A (0.44) | SCN10AHTR2CEPHX1 | |
| SCHEMBL1546444 | 0.83 | DRD2 (0.60) | — | |
| SCHEMBL1546446 | 0.83 | DRD2 (0.60) | — | |
| SCHEMBL25240758 | 0.81 | HTR2C (0.54) | SCN10AHTR2C | |
| SCHEMBL28247613 | 0.80 | MEN1 (0.48) | SCN10AHTR2CEPHX1 | |
| Trifluoroacetic Acid SCHEMBL942293 | 0.80 | EPHX1 (0.52) | HTR2CEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227428-A1 | AMIDO COMPOUNDS | Anaxis Pharma Pty Ltd (AU) | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227428-A1 | AMIDO COMPOUNDS | RIPK1, RIPK3, MLKL | HTR3A 3838/4885SCN10A 1485/4885HTR2C 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.